AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 211 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $956,362 | -20.6% | 20,795 | -0.7% | 0.53% | -14.2% |
| Q2 2023 | $1,204,111 | -61.0% | 20,952 | -74.5% | 0.61% | -64.4% |
| Q1 2023 | $3,084,488 | +35.4% | 82,253 | +1.2% | 1.72% | +21.9% |
| Q4 2022 | $2,277,662 | +0.8% | 81,287 | +1.1% | 1.41% | -6.7% |
| Q3 2022 | $2,259,000 | +75.0% | 80,399 | +116.6% | 1.52% | +84.8% |
| Q2 2022 | $1,291,000 | +6.4% | 37,117 | +9.8% | 0.82% | +32.9% |
| Q1 2022 | $1,213,000 | – | 33,794 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LAM GROUP, INC. | 130,250 | $4,884,375 | 4.79% |
| SHAKER INVESTMENTS LLC/OH | 82,253 | $3,084,488 | 1.72% |
| Mesirow Institutional Investment Management, Inc. | 325,669 | $12,212,588 | 1.33% |
| Portolan Capital Management | 340,593 | $12,772,238 | 1.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 178,200 | $6,682,500 | 1.04% |
| Granite Investment Partners, LLC | 536,821 | $20,130,788 | 0.84% |
| Capital Impact Advisors, LLC | 15,304 | $573,900 | 0.70% |
| Hillsdale Investment Management Inc. | 155,038 | $5,813,926 | 0.50% |
| GLOBEFLEX CAPITAL L P | 89,192 | $3,344,700 | 0.41% |
| Jackson Creek Investment Advisors LLC | 25,877 | $970 | 0.41% |